David Toung analyst ARGUS

Currently out of the existing stock ratings of David Toung, 28 are a HOLD (12.84%), 190 are a BUY (87.16%).

David Toung

Work Performance Price Targets & Ratings Chart

Analyst David Toung, currently employed at ARGUS, has had 64.91% of price targets met with an average potential upside of 22.86%, reached in 422 days on average.

David Toung has documented 402 price targets and ratings displayed on 35 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on CAH, Cardinal Health.

Wall Street Analyst David Toung

Analyst best performing recommendations are on IQV (IQVIA HOLDINGS).
The best stock recommendation documented was for HUM (HUMANA) on 8/14/2025. The price target of $281.99 was fulfilled within 1 day with a profit of $4.65 (1.68%), with a performance score of 16.77.

Average potential price target upside

MDT Medtronic PLC MRK Merck mpany TECH Bio-Techne Corp TMO Thermo Fisher Scientific ZBH Zimmer Biomet Holdings ABBV AbbVie ABC AmerisourceBergen BDX Becton Dickinson and Company CRL Charles River Laboratories CTLT Catalent HUM Humana ISRG Intuitive Surgical MCK McKesson UNH UnitedHealth Group BMY Bristol-Myers Squibb Company CELG Celgene GILD Gilead Sciences HOLX Hologic AZN AstraZeneca PLC ADR LLY Eli Lilly and Company PFE Pfizer SILK Silk Road Medical SYK Stryker AMGN Amgen DHR Danaher HCA HCA Holdings CAH Cardinal Health ABT Abbott Laboratories AGN Allergan plc ELV Elevance Health JNJ Johnson & Johnson IART Integra LifeSciences Holdings COR Cencora GEHC GE HealthCare Technologies IQV IQVIA Holdings

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 18-Aug-2026

$99

$-3.86 (-3.75%)

$100

1 months 5 days ago
(12-Oct-2026)

5/7 (71.43%)

$7.07 (7.69%)

107

Hold Since 07-Oct-2026

$95

$-7.86 (-7.64%)

$120

1 months 10 days ago
(07-Oct-2026)

12/33 (36.36%)

$9.49 (11.10%)

897

Buy Since 08-Jan-2020

$110

$7.14 (6.94%)

$110

1 months 18 days ago
(30-Sep-2026)

14/28 (50%)

$23.71 (27.48%)

650

Buy Since 03-Sep-2026

$110

$7.14 (6.94%)

2 months 14 days ago
(03-Sep-2026)

3/4 (75%)

$17.66 (19.12%)

89

Hold Since 27-May-2022

$99

$-3.86 (-3.75%)

2 months 15 days ago
(02-Sep-2026)

28/33 (84.85%)

$7.57 (8.28%)

465

Show more analysts

Please expand the browser size to see the chart

Which stock is David Toung most bullish on?

Potential upside of $79.78 has been obtained for TMO (THERMO FISHER SCIENTIFIC)

Which stock is David Toung most reserved on?

Potential downside of -$87.97 has been obtained for CRL (CHARLES RIVER LABORATORIES)

What Year was the first public recommendation made by David Toung?

On 2011
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?